High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
about
PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilitiesDendritic Polymers for TheranosticsMetalloprotein-based MRI probesLanthanide probes for bioresponsive imagingImaging Renal Urea Handling in Rats at Millimeter Resolution using Hyperpolarized Magnetic Resonance Relaxometry.Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersAdvances in BioconjugationMultimodality and nanoparticles in medical imagingDiscrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agentIs macrocycle a synonym for kinetic inertness in Gd(III) Complexes? Effect of coordinating and noncoordinating substituents on inertness and relaxivity of Gd(III) chelates with DO3A-like ligands.Self-aggregated dinuclear lanthanide(III) complexes as potential bimodal probes for magnetic resonance and optical imaging.Aryl-phosphonate lanthanide complexes and their fluorinated derivatives: investigation of their unusual relaxometric behavior and potential application as dual frequency 1H/19F MRI probes.Manganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.Design of a Gd-DOTA-phthalocyanine conjugate combining MRI contrast imaging and photosensitization properties as a potential molecular theranostic.Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging.A water-soluble and water-coordinated Mn(II) complex: synthesis, characterization and phantom MRI image study.Exceptionally Inert Lanthanide(III) PARACEST MRI Contrast Agents Based on an 18-Membered Macrocyclic Platform.A Theranostic Agent Combining a Two-Photon-Absorbing Photosensitizer for Photodynamic Therapy and a Gadolinium(III) Complex for MRI Detection.Silica-Coated Metal Chelating-Melanin Nanoparticles as a Dual-Modal Contrast Enhancement Imaging and Therapeutic Agent.Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.A copper-activated magnetic resonance imaging contrast agent with improved turn-on relaxivity response and anion compatibility.Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging.Bifunctional Eu(3+)-doped Gd(2)O(3) nanoparticles as a luminescent and T(1) contrast agent for stem cell labeling.Functional viral metagenomics and the next generation of molecular toolsChallenges for Molecular Neuroimaging with MRI.Peptide-targeted Nanoglobular Gd-DOTA monoamide conjugates for magnetic resonance cancer molecular imagingNext-generation probes, particles, and proteins for neural interfacing.Activatable T₁ and T₂ magnetic resonance imaging contrast agentsFacile synthesis of non-ionic dimeric molecular resonance imaging contrast agent: its relaxation and luminescence studies.Using the antenna effect as a spectroscopic tool: photophysics and solution thermodynamics of the model luminescent hydroxypyridonate complex [Eu(III)(3,4,3-LI(1,2-HOPO))]-.Integrin Targeted MR Imaging.Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.Self-assembly and alterable relaxivity of an organic cation-encapsulated gadolinium-containing polyoxometalate.(Gd,Yb,Tb)PO4 up-conversion nanocrystals for bimodal luminescence-MR imaging.A hexanuclear gadolinium-organic octahedron as a sensitive MRI contrast agent for selectively imaging glucosamine in aqueous media.A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease modelBiodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imagingCoupling fast water exchange to slow molecular tumbling in Gd3+ chelates: why faster is not always better.New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.
P2860
Q24594884-3F8F48B2-D11A-4429-BD39-E2A76A9AAC66Q26746182-EB939368-F13A-447F-8511-8B26A38B67FBQ26849668-E077583B-3057-486B-9114-749098524E6EQ27000361-1C152B51-7F8C-4369-AF8C-B11819B8BDB9Q27342014-278E2FD2-B51E-4FED-9F3C-6B3E6384B94EQ28235682-46BD2625-5564-4177-9F5A-7D76E57003D5Q28287639-CD0B16CA-5C52-41DA-9824-C505003324B7Q30407070-BF759B4A-866D-4830-978D-38D5ED124870Q30576125-763B4513-7ECA-4E40-B0AF-E5F0AFAA6F1CQ30604750-32E9201D-DDFD-4024-BF00-6AFBDC7540C4Q30654757-00E8D747-DC59-4CC5-A151-EB133FB92245Q30656068-F7C45611-2C9E-4751-A329-EA30B8D45E4BQ30722696-F4506F99-96E4-4601-A78A-31CCBF05E70CQ30843294-F13EEB05-A143-4FD2-B014-1AF328ECCEB3Q30857901-FDFDCD10-2EEA-459B-8E32-75F287FE3B20Q30978230-3DD6B227-E15E-426F-B31E-BE10CC9548E0Q31018158-9494A696-C130-4315-A55F-CDFB5C947AEAQ31038537-7CEDF336-08DC-4ECB-ADC7-FCC3CCAC8C74Q31149990-4D85F607-1E2C-489D-AF87-E6AD1F429AC3Q33463644-36961D44-BF20-414C-AF55-5CEAE370ADDFQ33519938-A6D73979-B3F9-42FB-8DE0-DD49C4C31058Q33555204-16F09903-85C7-4EE1-97F5-60989C5A7FFBQ33564661-1396B8A4-A6AA-475D-8186-3A45E705B374Q33637263-33F7E0F6-456D-4765-A226-536FA735F91FQ33680025-7747574C-08C0-45D6-94FF-E18412F8A638Q33782280-B83705B2-4E26-412B-ABF9-AA750E7E76C1Q33783880-5EBEDBCB-CB63-472D-A5E1-885BD9615BE5Q33823740-676132CF-A0F9-49AB-B303-2A01AE67AA4DQ33828889-CC651461-9D90-4C78-B268-993D5757031AQ33866083-21B4F8D9-BEC1-48F6-B053-2D4E35892AAFQ33890945-3AE60343-965F-4837-B2D5-ACAF04AE9513Q34161701-1C23BE3D-9081-43F4-B96B-949BDEC576AAQ34192364-D30467D5-CB27-447C-99BA-90E2B96EF210Q34290453-87E45A14-E29A-478C-943A-34BB67D19235Q34338031-8F8DD096-805C-45A7-8E5A-910F51091781Q34371958-43751975-9CE9-4525-8D77-0CC869412058Q34568075-B1A9276B-E767-4CA4-83AD-845ECF90FE70Q34683486-A24EBB7E-4424-404D-B6C5-E9BE9FF1BF57Q34809764-91D2A3DE-FF8B-4C32-AC8A-EFA7C79D5709Q35060340-F75044F0-5A85-41EA-B53A-F0ECB6C5C9B4
P2860
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
@en
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
@nl
type
label
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
@en
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
@nl
prefLabel
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
@en
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
@nl
P2093
P356
P1476
High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
@en
P2093
Ankona Datta
Christoph J Jocher
Eric J Werner
Kenneth N Raymond
P304
P356
10.1002/ANIE.200800212
P407
P577
2008-01-01T00:00:00Z